WA Health Founders Hope to Revolutionise Cancer Treatments

WA health founders hope to revolutionise cancer treatments

Two WA health professionals knew they needed to revolutionise the way chemotherapy and immunotherapy were administered after spending years observing cancer patients in waiting rooms struggling with fatigue.

Revolutionary new cancer drug to be trialled at Canberra Hospital

ANU scientists trial new drug PMR-116 targeting aggressive, untreatable cancers by addressing MYC gene abnormalities. Hope for treatment advances.

World-first "undruggable" cancer treatment enters human trial

A promising new treatment to combat "undruggable" cancers has been green-lit for a human trial in 2025. It's hoped the novel drug will be able to stunt the growth and enable the effective treatment of cancers driven by the MYC oncogene and its MYC protein.Continue ReadingCategory: Cancer, Illnesses and conditions, Body & MindTags: Australian National University, Peter MacCallum Cancer Centre, Cancer, clinical trials, Drug, Treatment, Tumors

Clinical trial set to drug the ‘undruggable’ cancers

A world-first clinical trial targeting cancers that are currently undruggable will begin later this year, led by a research team from The Australian National University (ANU) and Canberra Health Services. The trial targets MYC-driven cancers – a group that includes multiple cancer types, including prostate, breast, ovarian, and haematological cancers.